Net Asset Value(s)
14/04/2022 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220414:nRSN3307Ia&default-theme=true
RNS Number : 3307I RTW Venture Fund Limited 14 April 2022
LEI: 549300Q7EXQQH6KF7Z84
14 April 2022
RTW Venture Fund Limited
Net Asset Value
RTW Venture Fund Limited (the "Company") announces that the unaudited net
asset value attributable to the ordinary shares of the Company at the close of
business on 31 March 2022 (the "NAV") was US$313.8 million, or US$1.48 per
ordinary share.
As at 31 March 2022, 33.9 per cent. of the total NAV was invested in
privately-held core portfolio companies and 33.2 per cent. of the total NAV
was invested in public core portfolio companies, most of which were initiated
as private investments.
For Further Information
RTW Investments,
LP
+1 (646) 343 9280
Stephanie Sirota, Chief Business Officer
Alexandra Taracanova, PhD, Director of Investor Relations
Julia Enright, Senior Business Development Associate
Elysium Fund Management Limited +44 (0) 14 8181 0100
Joanna Duquemin Nicolle, Chief Executive Officer
Sadie Morrison, Managing Director
Morgan Stanley Fund Services USA LLC +1 (914) 225 8885
J.P. Morgan
Cazenove
+44 (0)20 7742 4000
William Simmonds
Jérémie Birnbaum
James Bouverat (Sales)
BofA
Securities
+44 (0) 20 7628 1000
Edward Peel
Kieran Millar
Note:
1. The NAV is determined by the Company's investment manager, RTW Investments,
LP, in accordance with the Company's accounting policies. Investments by the
Company in privately-held companies ("Private Portfolio Companies") have been
valued at fair market value, taking into account the valuation prepared by
Alvarez & Marsal Valuation Services LLC and the nature, facts and
circumstances of the Private Portfolio Companies. Investments by the Company
in companies listed on a public stock exchange (the "Public Portfolio
Companies") have each been valued by reference to their market capitalisation
as at close of business on 31 March 2022. The Company applies a valuation
discount to its investments in Public Portfolio Companies that are subject to
post-IPO lock-up provisions.
About RTW Venture Fund Limited:
RTW Venture Fund Limited (LSE: RTW & RTWG) is an investment fund focused
on identifying transformative assets with high growth potential across the
biopharmaceutical and medical technology sectors. Driven by a long-term
approach to support innovative businesses, RTW Venture Fund invests in
companies developing next-generation therapies and technologies that can
significantly improve patients' lives.
RTW Venture Fund Limited is managed by RTW Investments, LP, a leading
healthcare-focused entrepreneurial investment firm with deep scientific
expertise and a strong track record of supporting companies developing
life-changing therapies.
Visit the RTW website at www.rtwfunds.com
(https://protect.mimecast-offshore.com/s/eY8OCgLEp4SlY4JEFN_vEF) for more
information.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NAVGPUCPCUPPGQW